Intracranial aneurysm rupture within three days after receiving mRNA anti-COVID-19 vaccination: Three case reports

CONCLUSION: Although the advantages of COVID-19 vaccination appear to outweigh the risks, pharmacovigilance must be maintained to monitor potentially fatal adverse events and identify possible associations.PMID:35509565 | PMC:PMC9062907 | DOI:10.25259/SNI_1144_2021
Source: Surgical Neurology International - Category: Neurosurgery Authors: Source Type: research